Related Experiment Video
Updated: Jun 1, 2026

Methods for Analyzing the Impacts of Natural Uranium on In Vitro Osteoclastogenesis
Published on: January 30, 2018
Febuxostat efficacy in allopurinol-resistant tophaceous gout
1Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
Abstract:
Allopurinol has been a standard hypouricemic agent for more than 40 years, but febuxostat, which is also a xanthine oxidase inhibitor, is now available. We present a case of tophaceous gout with uric acid levels that did not respond to prescription of very high doses of allopurinol or uricosuric agents. With febuxostat treatment, the patient had rapid and sustained reduction in her uric acid levels to target range. This case raises the possibility of currently unrecognized pharmacologic differences between allopurinol and febuxostat.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Urinary Tract Calculi III: Medical Management
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Phase II Reactions: Glucuronidation
Drug Metabolism: Phase II Reactions
Renal Drug Excretion: Tubular Secretion